S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

实时更新: Elekta AB (publ) [EKTAY]

交易所: OTC 部门: Healthcare 工业: Medical Instruments & Supplies
最后更新时间4 May 2024 @ 03:57

0.64% $ 7.07

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 03:57):

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology...

Stats
今日成交量 14 150.00
平均成交量 9 630.00
市值 2.71B
EPS $0 ( 2024-03-01 )
下一个收益日期 ( $0 ) 2024-06-05
Last Dividend $0.117 ( 2023-08-25 )
Next Dividend $0 ( N/A )
P/E 20.79
ATR14 $0.0430 (0.61%)

Elekta AB (publ) 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Elekta AB (publ) 财务报表

Annual 2023
营收: $16.87B
毛利润: $6.35B (37.64 %)
EPS: $2.47
FY 2023
营收: $16.87B
毛利润: $6.35B (37.64 %)
EPS: $2.47
FY 2022
营收: $14.55B
毛利润: $5.44B (37.37 %)
EPS: $3.02
FY 2021
营收: $13.76B
毛利润: $5.61B (40.76 %)
EPS: $3.28

Financial Reports:

No articles found.

Elekta AB (publ) Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.118
(N/A)
$0
(N/A)
$0.118
(N/A)
$0
(N/A)
$0.117
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Elekta AB (publ) Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.56 - Stable (11.21%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.305 2013-09-04
Last Dividend $0.117 2023-08-25
Next Dividend $0 N/A
Payout Date 2023-09-15
Next Payout Date N/A
# dividends 18 --
Total Paid Out $1.985 --
Avg. Dividend % Per Year 0.00% --
Score 3.93 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.56
Div. Directional Score 9.15 --
Next Divdend (Est)
(2024-10-03)
$0.123 Estimate 7.07 %
Dividend Stability
0.28 Very Poor
Dividend Score
3.93
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
UEPCO Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
JMPLY Ex Dividend Knight 2023-06-15 Semi-Annually 0 0.00%
BKHYY Ex Dividend Junior 2023-08-25 Annually 0 0.00%
RMYHY Ex Dividend Junior 2023-09-05 Semi-Annually 0 0.00%
EVSBY Ex Dividend Knight 2023-05-24 Annually 0 0.00%
WJRYF Ex Dividend Junior 2023-09-28 Annually 0 0.00%
LNSTY Ex Dividend Knight 2023-08-17 Semi-Annually 0 0.00%
CGEMY Ex Dividend Knight 2023-05-25 Annually 0 0.00%
SLVYY Ex Dividend Knight 2023-05-15 Semi-Annually 0 0.00%
GBLBY Ex Dividend Junior 2023-05-11 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07861.5008.4310.00[0 - 0.5]
returnOnAssetsTTM0.04661.2008.4510.00[0 - 0.3]
returnOnEquityTTM0.1411.5009.5410.00[0.1 - 1]
payoutRatioTTM0.640-1.0003.60-3.60[0 - 1]
currentRatioTTM1.0950.8009.537.62[1 - 3]
quickRatioTTM0.8220.8009.877.90[0.8 - 2.5]
cashRatioTTM0.1811.500-0.104-0.156[0.2 - 2]
debtRatioTTM0.198-1.5006.70-10.00[0 - 0.6]
interestCoverageTTM6.241.0008.808.80[3 - 30]
operatingCashFlowPerShareTTM8.212.007.2610.00[0 - 30]
freeCashFlowPerShareTTM3.982.008.0110.00[0 - 20]
debtEquityRatioTTM0.593-1.5007.63-10.00[0 - 2.5]
grossProfitMarginTTM0.3771.0007.047.04[0.2 - 0.8]
operatingProfitMarginTTM0.1291.0009.419.41[0.1 - 0.6]
cashFlowToDebtRatioTTM0.5161.0008.258.25[0.2 - 2]
assetTurnoverTTM0.5930.8009.387.50[0.5 - 2]
Total Score12.75

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM20.391.0008.040[1 - 100]
returnOnEquityTTM0.1412.509.7010.00[0.1 - 1.5]
freeCashFlowPerShareTTM3.982.008.6710.00[0 - 30]
dividendYielPercentageTTM0.02831.5009.290[0 - 0.4]
operatingCashFlowPerShareTTM8.212.007.2610.00[0 - 30]
payoutRatioTTM0.6401.5003.60-3.60[0 - 1]
pegRatioTTM-0.1041.500-4.020[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1721.0008.200[0.1 - 0.5]
Total Score5.56

Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。